Cite
Eligibility and Rate of Treatment for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Using Different Criteria.
MLA
Poyin Huang, et al. “Eligibility and Rate of Treatment for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Using Different Criteria.” Academic Emergency Medicine, vol. 18, no. 3, Mar. 2011, pp. 273–78. EBSCOhost, https://doi.org/10.1111/j.1553-2712.2011.01006.x.
APA
Poyin Huang, Gim-Thean Khor, Chun-Hung Chen, Ruey-Tay Lin, & Ching-Kuan Liu. (2011). Eligibility and Rate of Treatment for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Using Different Criteria. Academic Emergency Medicine, 18(3), 273–278. https://doi.org/10.1111/j.1553-2712.2011.01006.x
Chicago
Poyin Huang, Gim-Thean Khor, Chun-Hung Chen, Ruey-Tay Lin, and Ching-Kuan Liu. 2011. “Eligibility and Rate of Treatment for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Using Different Criteria.” Academic Emergency Medicine 18 (3): 273–78. doi:10.1111/j.1553-2712.2011.01006.x.